Current evidence of effects of Helicobacter pylori eradication on prevention of gastric cancer
The Korean Journal of Internal Medicine
;
: 525-537, 2013.
Artículo
en Inglés
| WPRIM
| ID: wpr-175099
ABSTRACT
Gastric cancer is the second most common cause of cancer death worldwide and is usually detected at a late stage, except in Korea and Japan where early screening is in effect. Results from animal and epidemiological studies suggest that Helicobacter pylori infection, and subsequent gastritis, promote development of gastric cancer in the infected mucosa. Relatively effective treatment regimens are available to treat H. pylori infection, and in general, mass eradication of the organism is not currently recommended as a gastric cancer prevention strategy. However, regional guidelines vary regarding the indications and recommendations for H. pylori treatment for gastric cancer prevention. In this review, we discuss the results from intervention studies, provide insight regarding current guideline recommendations, and discuss future study directions.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Neoplasias Gástricas
/
Factores de Riesgo
/
Infecciones por Helicobacter
/
Resultado del Tratamiento
/
Guías de Práctica Clínica como Asunto
/
Medicina Basada en la Evidencia
/
Quimioterapia Combinada
/
Inhibidores de la Bomba de Protones
/
Detección Precoz del Cáncer
/
Gastrectomía
Tipo de estudio:
Estudio diagnóstico
/
Estudio de etiología
/
Guía de Práctica Clínica
/
Factores de riesgo
/
Estudio de tamizaje
Límite:
Humanos
Idioma:
Inglés
Revista:
The Korean Journal of Internal Medicine
Año:
2013
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS